Therefore, the purpose of this study is to investigate whether PLG is effective in treating AD in DNCB-induced atopic dermatitis-like animal models and TNF-α/IFN-γ-stimulated HaCaT cell models. The gene discussed is IFNG; the disease is atopic eczema.